PDS Biotechnology Valuation Multiples

PDS Biotechnology Overview

About PDS Biotechnology

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Founded

2009

HQ

Employees

24

Website

pdsbiotech.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

EBITDA: ($35M)

EV

$29M

Valuation Multiples

Multiples.vc

Start free trial

PDS Biotechnology Financials

PDS Biotechnology reported last 12-month revenue of — and negative EBITDA of ($35M).

In the same LTM period, PDS Biotechnology generated — in gross profit, ($35M) in EBITDA losses, and had net loss of ($38M).

PDS Biotechnology P&L

In the most recent fiscal year, PDS Biotechnology reported revenue of — and EBITDA of ($34M).

PDS Biotechnology expects next 12-month revenue of XXX and NTM EBITDA of XXX

PDS Biotechnology Stock Performance

PDS Biotechnology has current market cap of $38M, and enterprise value of $29M.

PDS Biotechnology's stock price is $0.69.

PDS Biotechnology Valuation Multiples

PDS Biotechnology trades at (0.8x) EV/EBITDA.

PDS Biotechnology Financial Valuation Multiples

As of March 18, 2026, PDS Biotechnology has market cap of $38M and EV of $29M.

Equity research analysts estimate PDS Biotechnology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

PDS Biotechnology has a P/E ratio of (1.0x).

PDS Biotechnology Margins & Growth Rates

PDS Biotechnology's revenue in the last fiscal year grew by —.

PDS Biotechnology's revenue per employee in the last FY averaged $0.0M.

PDS Biotechnology Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

PDS Biotechnology M&A Activity

PDS Biotechnology acquired XXX companies to date.

Last acquisition by PDS Biotechnology was on XXXXXXXX, XXXXX. PDS Biotechnology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

PDS Biotechnology Investment Activity

PDS Biotechnology invested in XXX companies to date.

PDS Biotechnology made its latest investment on XXXXXXXX, XXXXX. PDS Biotechnology invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).